A new feasible method for fibrinogen purification based on the affinity of Staphylococcus aureus clumping factor A to fibrinogen

Protein Expression and Purification

Volumn 61, Issue 1, 2008, Pages 31-35

  Liu, Chao Zong ^a   Cheng, Hui Ju ^a   Chang, Ling Ya ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Affinity purification; Clumping factor A; Fibrinogen

Indexed keywords

CLFA PROTEIN, STAPHYLOCOCCUS AUREUS; COAGULASE; FIBRINOGEN; PRIMER DNA;

AFFINITY CHROMATOGRAPHY; ANIMAL; ARTICLE; CELL ADHESION; FEASIBILITY STUDY; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; RAT; THROMBOCYTE AGGREGATION;

ANIMALS; BASE SEQUENCE; CELL ADHESION; CHROMATOGRAPHY, AFFINITY; COAGULASE; DNA PRIMERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEASIBILITY STUDIES; FIBRINOGEN; HUMANS; MICE; PLATELET AGGREGATION; RATS;

BACTERIA (MICROORGANISMS); RATTUS; STAPHYLOCOCCUS AUREUS;

EID: 47749153726     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2008.05.007     Document Type: Article

References (25)

1. Weisel J.W., Stauffacher C.V., Bullitt E., and Cohen C. A model for fibrinogen: domains and sequence. Science 230 (1985) 1388-1391
2. Mosesson M.W. Fibrinogen and fibrin structure and functions. J. Thromb. Haemost. 3 (2005) 1894-1904
3. Ye Q., Zund G., Benedikt P., Jockenhoevel S., Hoerstrup S.P., Sakyama S., Hubbell J.A., and Turina M. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur. J. Cardiolthorac. Surg. 17 (2000) 587-591
4. Mol A., van Lieshout M.I., Dam-de Veen C.G., Neuenschwander S., Hoerstrup S.P., Baaijens F.P., and Bouten C.V. Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials 26 (2005) 3113-3121
5. Wong C., Inman E., Spaethe R., and Helgerson S. Fibrin-based biomaterials to deliver human growth factors. Thromb. Haemost. 89 (2003) 573-582
6. Kuyas C., Haeberli A., Walder P., and Straub P.W. Isolation of human fibrinogen and its derivatives by affinity chromatography on Gly-Pro-Arg-Pro-Lys-Fractogel. Thromb. Haemost. 63 (1990) 439-444
7. Kaufman D.B., Hentsch M.E., Baumbach G.A., Buettner J.A., Dadd C.A., Huang P.Y., Hammond D.J., and Carbonell R.G. Affinity purification of fibrinogen using a ligand from a peptide library. Biotechnol. Bioeng. 77 (2002) 278-289
8. Takebe M., Soe G., Kohno I., Sugo T., and Matsuda M. Calcium ion-dependent monoclonal antibody against human fibrinogen preparation, characterization, and application to fibrinogen purification. Thromb. Haemost. 73 (1995) 662-667
9. Dempfle C.E., and Heene D.L. Purification of human plasma fibrinogen by chromatography on protamine-agarose. Thromb. Res. 46 (1987) 19-27
10. Jennissen H.P., and Demiroglou A. Interaction of fibrinogen with n-alkylagaroses and its purification by critical hydrophobicity hydrophobic interaction chromatography. J. Chromatogr. A 1109 (2006) 197-213
11. Foster T.J., and Höök M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 6 (1998) 484-488
12. Hawiger J., Timmons S., Strong D.D., Cottrell B.A., Riley M., and Doolittle R.F. Identification of a region of human fibrinogen interacting with staphylococcal clumping factor. Biochemistry 21 (1982) 1407-1413
13. McDevitt D., Nanavaty T., House-Pompeo K., Bell E., Turner N., McIntire L., Foster T.J., and Höök M. Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen. Eur. J. Biochem. 247 (1997) 416-424
14. 221-550, a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function. Thromb. Haemost. 94 (2005) 286-294
15. 221-550) inhibits platelet-plug formation in mice. Thromb. Res. 121 (2007) 183-191
16. Liu C.Z., Wu T.F., Huang T.F., Wu D.H., and Lin G.L. Trimucytin, a collagen-like snake venom protein, activates platelets independent of I-domain within α2 subunit of α2β1 integrin. Thromb. Res. 105 (2002) 153-160
17. Liu C.Z., and Huang T.F. Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction. Arch. Biochem. Biophys. 337 (1997) 291-299
18. Bellavite P., Andrioli G., Guzzo P., Arigliano P., Chirumbolo S., Manzato F., and Santonastaso C. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal. Biochem. 216 (1994) 444-450
19. Siebenlisk K.R., Meh D.A., and Mosesson M.W. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Thromb. Haemost. 86 (2001) 1221-1228
20. Siebenlist K.R., and Mosesson M.W. Progressive cross-linking of fibrin γ chains increases resistance to fibrinolysis. J. Biol. Chem. 269 (1994) 28414-28419
21. Siebenlist K.R., Meh D.A., and Mosesson M.W. Plasma factor XIII binds specifically to fibrinogen molecules containing γ′ chains. Biochemistry 35 (1996) 10448-10453
22. Murakawa M., Okamura T., Kamura T., Shibuya T., Harada M., and Niho Y. Diversity of primary structures of the carboxy-terminal regions of mammalian fibrinogen Aα chains. Thromb. Haemost. 69 (1993) 351-360
23. Doolittle R.F., and Kollman J.M. Natively unfolded regions of the vertebrate fibrinogen molecule. Proteins 63 (2006) 391-397
24. Holmbäck K., Danton M.J., Suh T.T., Dauhterty C.C., and Degen J.L. Impaired platelet aggregation and sustained bleeding in mice lacking the fibrinogen motif bound by integrin αIIbβ3. EMBO J. 15 (1996) 5760-5771
25. Cunningham M.T., Brandt J.T., Laposata M., and Olson J.D. Laboratory diagnosis of dysfibrinogenemia. Arch. Pathol. Lab. Med. 126 (2002) 499-505